Categories: FinancialsPSX Blog

Lotchem reports higher volumetric sales but struggles with margins, other income

Lotte Chemical Pakistan Limited (LOTCHEM) recently released its financial results for 2QCY24 and the numbers have sparked interest.

The company reported earnings of Rs0.84 per share, which is a significant increase of 4.1 times year-on-year (YoY) and 42% quarter-on-quarter (QoQ).

This brings the total earnings for the first half of 2024 to Rs1.43 per share, although this is down 24% compared to the same period last year.

The jump in earnings is primarily due to higher volumetric sales during the quarter.

Despite a challenging economic environment, LOTCHEM managed to increase its revenue by 95% YoY to Rs32.1 billion in 2QCY24.

This growth was driven by increased sales volumes and a higher sales premium, even though the average price of purified terephthalic acid (PTA) declined by 1% YoY to US$802 per ton during the quarter.

Challenges with margins and costs

The company’s gross margins took a hit, declining by 5 percentage points YoY to 7.2% in 2QCY24.

Several factors contributed to this decline, including higher gas prices, a 9% YoY drop in PTA-paraxylene (PX) margins, and a 3% YoY appreciation of the Pakistani Rupee against the US Dollar.

These challenges highlight the ongoing pressures on the company’s cost structure.

Additionally, other income for LOTCHEM fell by 39% YoY in 2QCY24, mainly due to a 26% YoY reduction in cash and short-term investments.

The finance cost also saw a significant increase of 48% YoY, further impacting the bottom line.

The company’s effective tax rate clocked in at 38.8%, which, while lower than the previous year, still represents a substantial burden on profitability.

Indicator2QCY242QCY23
Gross Margin7.2%12.2%
Net Profit Margin4.0%1.9%
Effective Tax Rate38.8%85.1%
Earnings Per Share (EPS)Rs0.84Rs0.21

What’s the outlook for LOTCHEM?

Looking ahead, analysts at Foundation Securities remain cautiously optimistic about LOTCHEM’s future performance.

The company has been given an “Outperform” rating, with a target price of Rs27.8 per share by December 2024.

This suggests that despite the challenges, LOTCHEM still holds potential for growth, particularly if it can navigate the cost pressures more effectively.

Source: Foundation Securities

Rameen Kasana

Recent Posts

AGP Healthcare for a Better Tomorrow

AGP Limited (AGP) monthly market structure is showing strong bullish trend. Even this stock broke…

1 week ago

Why dividends cause share price drop if they’re paid from earnings?

When a dividend is paid, the share price drops by approximately the same amount because…

3 weeks ago

MUGHAL right shares – 3 things to know before subscribing

On November 5, 2024, Mughal Iron & Steel Industries Limited (MUGHAL) announced a unique rights…

4 weeks ago

How to analyze pharmaceutical sector

How to analyze pharma sector companies in PSX. Pakistan's pharma sector is considered a complicated…

1 month ago

Shifa International (SHFA) has returned 150% in two months, will the rally continue?

Shifa International (SHFA) has already rallied 150%, but there is still more upside to the…

2 months ago

How is HMB handling financial challenges to grow?

Habib Metropolitan Bank Limited (HMB) recently released its second-quarter results for 2024, revealing a mixed…

3 months ago